Physician profile
Louis V Greer
NPI 1154380558
$3,383.76
in general payments reported to CMS, 2019-2025
23 companies · $736 in 2025
The $736 reported for 2025 was more than what 81% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $179 · 2021: $164 · 2022: $379 · 2023: $1,040 · 2024: $683 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,458.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,104.02 | 2019-2025 | Stravix, Collagenase Santyl, Stravix Mesh |
| Stryker Corporation | $361.12 | 2022-2024 | Bioskin, Allograft Bio-Implants, Citrefix |
| Cashflow Solutions, LLC | $178.94 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Lifenet Health | $116.31 | 2023 | |
| Pfizer INC. | $111.25 | 2019 | |
| Integra Lifesciences Corporation | $59.50 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $52.19 | 2023-2025 | Novosorb Btm |
| Acera Surgical, INC. | $51.74 | 2025 | Restrata Wound Matrix |
| Kowa Pharmaceuticals America, INC. | $47.52 | 2023 | Seglentis |
| Nevro Corp. | $37.80 | 2022 | |
| Tactile Systems Technology INC | $34.93 | 2023 | Flexitouch Plus, Entre Plus |
| Biocomposites INC | $32.62 | 2025 | Stimulan |
| Abbvie INC. | $29.89 | 2021 | |
| Sebela Pharmaceuticals INC. | $22.38 | 2021 | |
| Globus Medical, INC. | $22.20 | 2025 | Senza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $19.60 | 2019 | |
| Kci USA, INC. | $17.62 | 2023 | Activ.A.C., Promogran Prisma |
| Orthofix Medical, INC. | $16.52 | 2025 | Physio-Stim |
| Grt US Holding, INC. | $15.12 | 2022 | |
| Reddress USA, INC. | $13.71 | 2021 | |
| Convatec INC. | $13.35 | 2023 | |
| Paragon 28, INC. | $12.74 | 2019 | |
| Axogen | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.